Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Jitao Yang. 2024. Applied Informatics. Applied Informatics
338
350
.
Kunpeng Du, Jingwen Zou, Baiyao Wang, Chunshan Liu, Muhammad Khan, Tao Xie, Xiaoting Huang, Piao Shen, Yunhong Tian & Yawei Yuan. (2022) A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology 13.
Crossref
Crossref
Bo Deng, Tianyu Sun, Bo Tang, Shaolin Tao, Poming Kang, Kai Qian, Bin Jiang, Kun Li, Kunkun Li, Jinghai Zhou, Ruwen Wang & Qunyou Tan. (2017) Surgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study. Oncotarget 8:63, pages 107089-107095.
Crossref
Crossref
Marjorie Reyes-Díaz, Tomas Lobos, Liliana Cardemil, Adriano Nunes-Nesi, Jorge Retamales, Laura Jaakola, Miren Alberdi & Alejandra Ribera-Fonseca. (2016) Methyl Jasmonate: An Alternative for Improving the Quality and Health Properties of Fresh Fruits. Molecules 21:6, pages 567.
Crossref
Crossref
Małgorzata Zając & Krzysztof Giannopoulos. (2015) Mutacje TP53 w nowotworach hematologicznych. Acta Haematologica Polonica 46:5, pages 327-338.
Crossref
Crossref
Wei Ju, Meili Zhang, Michael Petrus, Michiyuki Maeda, Cynthia A Pise-Masison & Thomas A Waldmann. (2014) Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia. Retrovirology 11:1.
Crossref
Crossref
T. Longerich. (2014) EEF1A2 inhibiert über eine PI3K/AKT/mTOR-abhängige Stabilisierung von MDM4 die p53-Funktion im LeberzellkarzinomEEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4. Der Pathologe 35:S2, pages 177-184.
Crossref
Crossref
Junsheng Fu, Huadong Chen, Dominique N. Soroka, Renaud F. Warin & Shengmin Sang. (2014) Cysteine-Conjugated Metabolites of Ginger Components, Shogaols, Induce Apoptosis through Oxidative Stress-Mediated p53 Pathway in Human Colon Cancer Cells. Journal of Agricultural and Food Chemistry 62:20, pages 4632-4642.
Crossref
Crossref
Rossella Pellegrino, Diego F. Calvisi, Olaf Neumann, Venkatesh Kolluru, Josephine Wesely, Xin Chen, Chunmei Wang, Torsten Wuestefeld, Sara Ladu, Nahla Elgohary, Justo Lorenzo Bermejo, Bernhard Radlwimmer, Martin Zörnig, Lars Zender, Frank Dombrowski, Matthias Evert, Peter Schirmacher & Thomas Longerich. (2014) EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma. Hepatology 59:5, pages 1886-1899.
Crossref
Crossref
Manujendra N Saha, Lugui Qiu & Hong Chang. (2013) Targeting p53 by small molecules in hematological malignancies. Journal of Hematology & Oncology 6:1.
Crossref
Crossref
Emanuela Grassilli, Robert Narloch, Elena Federzoni, Leonarda Ianzano, Fabio Pisano, Roberto Giovannoni, Gabriele Romano, Laura Masiero, Biagio Eugenio Leone, Serena Bonin, Marisa Donada, Giorgio Stanta, Kristian Helin & Marialuisa Lavitrano. (2013) Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy. Clinical Cancer Research 19:14, pages 3820-3831.
Crossref
Crossref
Taketo Okubo, Tsuyoshi Saito, Hiroyuki Mitomi, Tatsuya Takagi, Tomoaki Torigoe, Yoshiyuki Suehara, Kazuo Kaneko & Takashi Yao. (2013) p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1. Virchows Archiv 463:1, pages 67-77.
Crossref
Crossref
S Liu, P Chen, M Hu, Y Tao, L Chen, H Liu, J Wang, J Luo & G Gao. (2013) Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer. Cancer Gene Therapy 20:6, pages 375-378.
Crossref
Crossref
Yin-Chun Liu, Yu-Jia Li & Chih-Ching Huang. (2012) Information Derived from Cluster Ions from DNA-Modified Gold Nanoparticles under Laser Desorption/Ionization: Analysis of Coverage, Structure, and Single-Nucleotide Polymorphism. Analytical Chemistry 85:2, pages 1021-1028.
Crossref
Crossref
Jenni K Peltonen, Kirsi H Vähäkangas, Henni M Helppi, Risto Bloigu, Paavo Pääkkö & Taina Turpeenniemi-Hujanen. (2011) Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study. Head & Neck Oncology 3:1.
Crossref
Crossref
Min Wu, Ryan T. Y. Wu, Thomas T. Y. Wang & Wen-Hsing Cheng. (2011) Role for p53 in Selenium-Induced Senescence. Journal of Agricultural and Food Chemistry 59:21, pages 11882-11887.
Crossref
Crossref
Sara Orgad, Hemi Dimant, Eyal Dor-On, Ronit Azriel-Rosenfeld, Itai Benhar & Beka Solomon. (2010) TAR1, A Human Anti-p53 Single-Chain Antibody, Restores Tumor Suppressor Function to Mutant p53 Variants. Journal of Immunotherapy 33:2, pages 146-154.
Crossref
Crossref
Pierre Hainaut. 2009. Genes and Common Diseases. Genes and Common Diseases
233
244
.
Samuel A. Danziger, Jue Zeng, Ying Wang, Rainer K. Brachmann & Richard H. Lathrop. (2007) Choosing where to look next in a mutation sequence space: Active Learning of informative p53 cancer rescue mutants. Bioinformatics 23:13, pages i104-i114.
Crossref
Crossref
Jianhua Wang, Zongzheng Ji & Xiaoqiang Wang. (2007) A study of the expression of p53 in posttransfection cells with rAdp53 gene and inhibitory activity in vitro. Journal of Nanjing Medical University 21:2, pages 120-124.
Crossref
Crossref
J Peltonen, J A Welsh & K H Vähäkangas. (2016) Is there a role for PCR-SSCP among the methods for missense mutation detection of TP53 gene?. Human & Experimental Toxicology 26:1, pages 9-18.
Crossref
Crossref
Bernd Nosse. (2006) Tumortherapien im Umbruch. Zielen lernen!. Chemie in unserer Zeit 40:3, pages 164-172.
Crossref
Crossref
Yon Jung ParkJing WenSeungmin BangSeung Woo ParkSi Young Song. (2006) [6]-Gingerol Induces Cell Cycle Arrest and Cell Death of Mutant p53-expressing Pancreatic Cancer Cells. Yonsei Medical Journal 47:5, pages 688.
Crossref
Crossref
Orit Fingrut, Dorit Reischer, Ronit Rotem, Natalia Goldin, Irit Altboum, Israel Zan-Bar & Eliezer Flescher. (2005) Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells. British Journal of Pharmacology 146:6, pages 800-808.
Crossref
Crossref
R Nenutil, J Smardova, S Pavlova, Z Hanzelkova, P Muller, P Fabian, R Hrstka, P Janotova, M Radina, DP Lane, PJ Coates & B Vojtesek. (2005) Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry. The Journal of Pathology 207:3, pages 251-259.
Crossref
Crossref
Sara Orgad, Naomi Goldfinger, Gerald Cohen, Varda Rotter & Beka Solomon. (2005) Single chain antibody against the common epitope of mutant p53 restores wild-type activity to mutant p53 protein. FEBS Letters 579:25, pages 5609-5615.
Crossref
Crossref